Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12991
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMihaly, G Wen
dc.contributor.authorChing, M Sen
dc.contributor.authorKlejn, M Ben
dc.contributor.authorPaull, Jen
dc.contributor.authorSmallwood, R Aen
dc.date.accessioned2015-05-16T02:45:41Z
dc.date.available2015-05-16T02:45:41Z
dc.date.issued1987-12-01en
dc.identifier.citationBritish Journal of Clinical Pharmacology; 24(6): 769-74en
dc.identifier.govdoc3440096en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12991en
dc.description.abstract1. Little is known about the comparative plasma protein binding of the antimalarial agents quinine (QN) and its isomer quinidine (QD). We have examined the in vitro binding of QN and QD to albumin, alpha 1-acid glycoprotein, normal human plasma, and maternal and foetal umbilical cord plasma. 2. QN was more avidly bound than QD, and binding of both drugs was substantially higher to alpha 1-acid glycoprotein than to albumin, indicating that alpha 1-acid glycoprotein is the more important binding protein. 3. Protein and drug concentration dependent binding was evident for both QN and QD. The unbound fraction of both drugs fell with increasing albumin (10 to 60 g l-1) and alpha 1-acid glycoprotein (0.5 to 2.0 g l-1) concentration, and there was a marked increase in unbound fraction of QN (6 to 19%) and QD (13 to 36%) in human plasma when drug concentrations were increased over the antimalarial therapeutic range (0.5 to 10 mg l-1). 4. In human volunteer plasma, the unbound fractions of QN and QD were 7.5 +/- 2.2% and 12.3 +/- 2.3% respectively, whilst the unbound fractions for both drugs were significantly higher in maternal plasma (QN = 13.0 +/- 5.4%, QD = 18.3 +/- 2.5%) and significantly higher still in foetal umbilical cord plasma (QN = 25.7 +/- 10%, QD = 35 +/- 5.3%).en
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherBlood Proteins.metabolismen
dc.subject.otherDialysisen
dc.subject.otherFemaleen
dc.subject.otherFetal Blood.analysisen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherOrosomucoid.metabolismen
dc.subject.otherProtein Bindingen
dc.subject.otherQuinidine.blooden
dc.subject.otherQuinine.blooden
dc.subject.otherSerum Albumin.metabolismen
dc.titleDifferences in the binding of quinine and quinidine to plasma proteins.en
dc.typeJournal Articleen
dc.identifier.journaltitleBritish journal of clinical pharmacologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Victoria, Australiaen
dc.description.pages769-74en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/3440096en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Feb 22, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.